Human trials of plant-based coronavirus ‘Baiya Vaccine’ begin next month
The vaccine will be ready for general use next year if human trials are successful, and it could also be further developed to fight variants of the coronavirus and help reduce its spread, Health Minister Anutin announced.
The Faculty of Pharmaceutical Sciences of Chulalongkorn University will start next month the first phase of clinical trials of Thailand’s plant-based coronavirus vaccine, the ‘Baiya vaccine’, in which 100 volunteers participate.
Health Minister Anutin Charnvirakul said during a visit to the vaccine production plant at Chulalongkorn University that if human trials are successful, the vaccine will be ready for general administration next year, adding that it could also be further developed to treat coronavirus variants. and help reduce its spread.
He said the development of the Baiya vaccine started in February last year and lab tests on mice and monkeys showed it to be highly effective at boosting the animals’ immunity. The Ministry of Health provided a grant of 160 million baht to finance the construction of a 1,200-square-meter factory to develop the vaccine prototype.
According to Mr Anutin, if all goes well, the factory could start production in the third quarter of next year, noting that the factory can produce up to 5 million doses per month.
Catch up on more stories here
Follow us on Facebook here